AcuityMD, the intelligence platform for MedTech, announced impressive growth and milestone achievements in 2024. Over the past year, AcuityMD contracted with its 300th customer, launched two innovative products, and doubled its staff. Further, after a $45 million Series B funding in June 2024, AcuityMD has now raised more than $83 million. With the global medical devices market size projected to grow from $542.21 billion in 2024 to $886.80 billion by 2032, AcuityMD is positioned for continued growth ahead.
AcuityMD combines accurate data on procedural volumes, site of care affiliations, and referral patterns with intuitive workflows to give companies the right insights they need to shorten sales cycles and get their innovative technology to patients faster.
Health Technology Insights: VSee Health Wins $444K Contract, Expanding in Public Sector Healthcare
Today, six of the top 10 MedTech companies, including Becton Dickinson and Company (BD), leverage AcuityMD’s intelligence platform to streamline their commercial operations and accelerate the adoption of life-changing medical innovations. Most recently, AcuityMD signed Teleflex Incorporated, a global provider of medical technologies that offers solutions across therapy areas, including interventional urology. Teleflex leverages AcuityMD to identify physicians with improved customer targeting strategies for its prostate health device portfolio.
“Teleflex has long utilized a range of commercialization tools to identify market opportunities, but previously, the information was fragmented, making it more challenging to extract actionable insights,” said Anthony Parrillo, vice president of global marketing, Interventional Urology, for Teleflex. “AcuityMD’s data enhances our ability to tell a comprehensive story about a patient’s complete care journey, allowing us to better demonstrate our product’s real value to physicians and sites of care. This platform is providing us with fresh perspectives on our business. In just a few months, our sales team has embraced AcuityMD for its added value, and we are actively rolling it out to all of our sales reps.”
Health Technology Insights: Colorado Cancer Center and Flatiron Health Partner to Improve Clinical Trials
AcuityMD Doubles Down on R&D Investment
In 2024, AcuityMD added two new modules, AcuityMD Contracts and AcuityMD Care Journeys, to its intelligence platform for MedTech.
- AcuityMD Contracts is the first contract management solution built to help MedTech companies increase contract revenue and penetration. It eliminates today’s biggest contract management bottlenecks to empower commercial teams to find untapped opportunities and accelerate sales cycles.
- AcuityMD Care Journeys enables MedTech companies to leverage longitudinal patient-level data to identify precise patient populations and demonstrate the clinical and financial impacts of their technology to healthcare executives.
AcuityMD also includes Markets, Pipeline, Targeting, and Territories. As the company continues its aggressive investment in advanced platform technology for the medical device industry, customers will see new solutions that incorporate AI to automate data management and streamline sales activity in 2025.
“Our dedicated team, loyal customers, and supportive partners are credited for making 2024 a transformative year for AcuityMD,” said Michael Monovoukas, CEO and co-founder of AcuityMD. “It’s extremely rewarding to have some of the most innovative MedTech companies relying on our platform to accelerate the adoption of their life-saving technologies. We are excited about the year ahead and remain committed to removing the challenges of bringing physicians and patients the latest innovations in care.”
Health Technology Insights: Radicle Science Unveils Journey: A New Innovation From the Healthtech Pioneer
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – businesswire
